Matches in SemOpenAlex for { <https://semopenalex.org/work/W1987169583> ?p ?o ?g. }
- W1987169583 endingPage "36.e18" @default.
- W1987169583 startingPage "36.e11" @default.
- W1987169583 abstract "Pseudomonas aeruginosa-mannose–sensitive hemagglutinin (PA-MSHA), a peritrichous P. aeruginosa strain with MSHA fimbriae, has been shown to be a valuable anticancer drug in many kinds of cancers. However, the effect of PA-MSHA on bladder cancer has not been elucidated. In this study, we focused on the antitumor activities and related mechanisms of PA-MSHA on bladder cancer in vitro and in vivo. SV-40-immortalized normal uroepithelial cells (SV-HUC-1) and human bladder cancer cell lines (T24, 5637, and HT-1376) were treated with PA-MSHA or PA (heat-killed P. aeruginosa). At first, the effect of PA-MSHA on cancer cell proliferation was measured using Cell Counting Assay Kit-8 (CCK-8), whereas the changes of cell morphology were observed by transmission electron microscopy. The early apoptosis induced by PA-MSHA was evaluated by flow cytometry, and the expression level of apoptosis-related molecules was detected using Western blot assay. We then investigated the activation of the epidermal growth factor receptor signaling pathway stimulated by PA-MSHA; the expression and phosphorylation of several key regulators involved in the EGFR signaling pathway were detected. At last, xenograft tumor in nude mice was used to further investigate the antitumor effect of PA-MSHA in vivo. Our results showed that PA-MSHA could efficiently inhibit proliferation and induce apoptosis in human bladder cancer cell lines. Furthermore, cells stimulated with PA-MSHA exhibited an inactivation of EGFR signaling. In vivo, PA-MSHA treatment significantly suppressed tumor growth and induced apoptosis in xenografts tumor in nude mice. PA-MSHA could efficiently inhibit proliferation and induce apoptosis in human bladder cancer cells in vitro and in vivo, which is associated with the inactivation of EGFR signaling pathway, and it might be used as a potential therapeutic agent for bladder cancer." @default.
- W1987169583 created "2016-06-24" @default.
- W1987169583 creator A5005098292 @default.
- W1987169583 creator A5014243738 @default.
- W1987169583 creator A5026506386 @default.
- W1987169583 creator A5045437842 @default.
- W1987169583 creator A5049692788 @default.
- W1987169583 creator A5058780708 @default.
- W1987169583 creator A5067637115 @default.
- W1987169583 creator A5075921281 @default.
- W1987169583 creator A5079886307 @default.
- W1987169583 creator A5081850178 @default.
- W1987169583 creator A5083374325 @default.
- W1987169583 creator A5084072550 @default.
- W1987169583 date "2014-01-01" @default.
- W1987169583 modified "2023-10-16" @default.
- W1987169583 title "Pseudomonas aeruginosa-mannose–sensitive hemagglutinin inhibits epidermal growth factor receptor signaling pathway activation and induces apoptosis in bladder cancer cells in vitro and in vivo" @default.
- W1987169583 cites W1964779071 @default.
- W1987169583 cites W1968842219 @default.
- W1987169583 cites W1998837519 @default.
- W1987169583 cites W2012197353 @default.
- W1987169583 cites W2028503090 @default.
- W1987169583 cites W2036360658 @default.
- W1987169583 cites W2043103956 @default.
- W1987169583 cites W2051471339 @default.
- W1987169583 cites W2062446427 @default.
- W1987169583 cites W2073723168 @default.
- W1987169583 cites W2078297328 @default.
- W1987169583 cites W2080961856 @default.
- W1987169583 cites W2086554622 @default.
- W1987169583 cites W2091267060 @default.
- W1987169583 cites W2096052997 @default.
- W1987169583 cites W2107498347 @default.
- W1987169583 cites W2119905488 @default.
- W1987169583 cites W2125441861 @default.
- W1987169583 cites W2136249816 @default.
- W1987169583 cites W2149967205 @default.
- W1987169583 doi "https://doi.org/10.1016/j.urolonc.2013.02.013" @default.
- W1987169583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23948182" @default.
- W1987169583 hasPublicationYear "2014" @default.
- W1987169583 type Work @default.
- W1987169583 sameAs 1987169583 @default.
- W1987169583 citedByCount "14" @default.
- W1987169583 countsByYear W19871695832015 @default.
- W1987169583 countsByYear W19871695832016 @default.
- W1987169583 countsByYear W19871695832017 @default.
- W1987169583 countsByYear W19871695832019 @default.
- W1987169583 countsByYear W19871695832020 @default.
- W1987169583 countsByYear W19871695832022 @default.
- W1987169583 countsByYear W19871695832023 @default.
- W1987169583 crossrefType "journal-article" @default.
- W1987169583 hasAuthorship W1987169583A5005098292 @default.
- W1987169583 hasAuthorship W1987169583A5014243738 @default.
- W1987169583 hasAuthorship W1987169583A5026506386 @default.
- W1987169583 hasAuthorship W1987169583A5045437842 @default.
- W1987169583 hasAuthorship W1987169583A5049692788 @default.
- W1987169583 hasAuthorship W1987169583A5058780708 @default.
- W1987169583 hasAuthorship W1987169583A5067637115 @default.
- W1987169583 hasAuthorship W1987169583A5075921281 @default.
- W1987169583 hasAuthorship W1987169583A5079886307 @default.
- W1987169583 hasAuthorship W1987169583A5081850178 @default.
- W1987169583 hasAuthorship W1987169583A5083374325 @default.
- W1987169583 hasAuthorship W1987169583A5084072550 @default.
- W1987169583 hasConcept C150903083 @default.
- W1987169583 hasConcept C153911025 @default.
- W1987169583 hasConcept C170493617 @default.
- W1987169583 hasConcept C185592680 @default.
- W1987169583 hasConcept C190283241 @default.
- W1987169583 hasConcept C207001950 @default.
- W1987169583 hasConcept C2779438470 @default.
- W1987169583 hasConcept C2780278673 @default.
- W1987169583 hasConcept C502942594 @default.
- W1987169583 hasConcept C55493867 @default.
- W1987169583 hasConcept C62112901 @default.
- W1987169583 hasConcept C86803240 @default.
- W1987169583 hasConceptScore W1987169583C150903083 @default.
- W1987169583 hasConceptScore W1987169583C153911025 @default.
- W1987169583 hasConceptScore W1987169583C170493617 @default.
- W1987169583 hasConceptScore W1987169583C185592680 @default.
- W1987169583 hasConceptScore W1987169583C190283241 @default.
- W1987169583 hasConceptScore W1987169583C207001950 @default.
- W1987169583 hasConceptScore W1987169583C2779438470 @default.
- W1987169583 hasConceptScore W1987169583C2780278673 @default.
- W1987169583 hasConceptScore W1987169583C502942594 @default.
- W1987169583 hasConceptScore W1987169583C55493867 @default.
- W1987169583 hasConceptScore W1987169583C62112901 @default.
- W1987169583 hasConceptScore W1987169583C86803240 @default.
- W1987169583 hasIssue "1" @default.
- W1987169583 hasLocation W19871695831 @default.
- W1987169583 hasLocation W19871695832 @default.
- W1987169583 hasOpenAccess W1987169583 @default.
- W1987169583 hasPrimaryLocation W19871695831 @default.
- W1987169583 hasRelatedWork W1968701816 @default.
- W1987169583 hasRelatedWork W2021792849 @default.
- W1987169583 hasRelatedWork W2157355069 @default.
- W1987169583 hasRelatedWork W2345263070 @default.
- W1987169583 hasRelatedWork W2350538445 @default.
- W1987169583 hasRelatedWork W2403560080 @default.